Economic evaluations in the critical care literature: do they help us improve the efficiency of our unit?

OBJECTIVE To determine the extent to which economic evaluations published in the critical care literature provide information that can help us to improve the efficiency of our unit. DATA SOURCES We searched computerized bibliographic databases and manually searched key critical care journals to retrieve all economic evaluations. STUDY SELECTION We included economic evaluations that dealt with clinical problems relevant to the practice of adult critical care and that compared competing healthcare interventions. DATA ABSTRACTION Included articles were further evaluated using criteria for minimal methodologic soundness, adopted from the literature, and criteria that we developed to assess the generalizability of results to our clinical setting. DATA SYNTHESIS We screened 4,167 papers manually and > 450 abstracts and titles in our computer search. One hundred fifty-one papers were retrieved for further evaluation; 29 papers met our inclusion criteria. Of these 29 papers, only 14 (48%) adequately described competing healthcare interventions, 17 (59%) provided sufficient evidence of clinical efficacy, six (21%) identified, measured, and valuated costs appropriately, and three (10%) performed a sensitivity analysis. None of the papers met all four of these criteria for a minimum level of methodologic soundness. Four (14%) of 29 studies which adequately dealt with issues of cost and efficacy were evaluated using our generalizability criteria. Different costing methods precluded the application of the results of three of the four studies to our intensive care unit. CONCLUSIONS In the critical care literature, very little useful economic information exists to help decision-makers maximize efficiency in their own setting.

[1]  A. Gafni,et al.  Cost-effectiveness ratios: in a league of their own. , 1994, Health policy.

[2]  Gordon H. Guyatt,et al.  Users' Guides to the Medical Literature: II. How to Use an Article About Therapy or Prevention B. What Were the Results and Will They Help Me in Caring for My Patients? , 1994 .

[3]  G H Guyatt,et al.  Users' guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group. , 1994, JAMA.

[4]  G H Guyatt,et al.  USERS' GUIDES TO THE MEDICAL LITERATURE. II: HOW TO USE AN ARTICLE ABOUT THERAPY OR PREVENTION A. ARE THE RESULTS OF THE STUDY VALID ? , 1993 .

[5]  M. Drummond,et al.  Standardizing Methodologies for Economic Evaluation in Health Care: Practice, Problems, and Potential , 1993, International Journal of Technology Assessment in Health Care.

[6]  L. Oppenheimer,et al.  Eliminating needless testing in intensive care—An information‐based team management approach , 1993, Critical care medicine.

[7]  David M. Eddy,et al.  Three Battles to Watch in the 1990s , 1993 .

[8]  D. Eddy Clinical decision making: from theory to practice. Three battles to watch in the 1990s. , 1993, JAMA.

[9]  W. R. Taylor,et al.  Health Care CBA/CEA: An Update on the Growth and Composition of the Literature , 1993, Medical care.

[10]  W. Knaus,et al.  Variations in Mortality and Length of Stay in Intensive Care Units , 1993, Annals of Internal Medicine.

[11]  A. Gafni,et al.  Discounting in the Economic Evaluation of Health Care Interventions , 1993, Medical care.

[12]  A. M. Hadbavny,et al.  Promotion of cost-effective benzodiazepine sedation. , 1993, American journal of hospital pharmacy.

[13]  K. Inman,et al.  Clinical utility and cost-effectiveness of an air suspension bed in the prevention of pressure ulcers. , 1993, JAMA.

[14]  M. Gaddis,et al.  Oral ranitidine as prophylaxis for gastric stress ulcers in intensive care unit patients: Serum concentrations and cost comparisons , 1993, Critical care medicine.

[15]  J. Studnicki,et al.  Intensive care, survival, and expense of treating critically ill cancer patients. , 1993, JAMA.

[16]  G. Carrasco,et al.  Propofol vs midazolam in short-, medium-, and long-term sedation of critically ill patients. A cost-benefit analysis. , 1993, Chest.

[17]  A. Fein,et al.  Cost-effectiveness of monoclonal antibodies to gram-negative endotoxin in the treatment of gram-negative sepsis in ICU patients. , 1993, JAMA.

[18]  A Gafni,et al.  Cost effectiveness/utility analyses. Do current decision rules lead us to where we want to be? , 1992, Journal of health economics.

[19]  D A Redelmeier,et al.  Variability among methods to assess patients' well-being and consequent effect on a cost-effectiveness analysis. , 1992, Journal of clinical epidemiology.

[20]  G A Colditz,et al.  Cost-Effectiveness and Cost-Benefit Analyses in the Medical Literature , 1992, Annals of Internal Medicine.

[21]  I. L. Cohen,et al.  Clinical utility and cost‐effectiveness of protective sleeve pulmonary artery catheters , 1991, Critical care medicine.

[22]  T. Noseworthy,et al.  National estimates of intensive care utilization and costs: Canada and the United States. , 1990, Critical care medicine.

[23]  W. Shoemaker,et al.  The efficacy of central venous and pulmonary artery catheters and therapy based upon them in reducing mortality and morbidity. , 1990, Archives of surgery.

[24]  M. Jastremski,et al.  Analysis of the effects of continuous on-line monitoring of mixed venous oxygen saturation on patient outcome and cost-effectiveness. , 1989, Critical care medicine.

[25]  S. Pohlman,et al.  Use of nonsterile gloves for routine noninvasive procedures in thermally injured patients. , 1988, The Journal of burn care & rehabilitation.

[26]  Newman Rh Bedside blood sugar determinations in the critically ill. , 1988 .

[27]  J. Thoner Outcome and costs of intensive care. A follow‐up study on patients requiring prolonged mechanical ventilation , 1987, Acta anaesthesiologica Scandinavica.

[28]  L. Maciorowski,et al.  Evaluation of the sterility of thermodilution room‐temperature injectate preparations , 1986, Critical care medicine.

[29]  B. Luce,et al.  Managing acute hypertension: cost considerations. , 1985, The American journal of emergency medicine.

[30]  B. Hamory,et al.  Comparison of three methods of maintaining a sterile injectate system during cardiac output determinations. , 1984, American journal of infection control.

[31]  T. V. Vander Salm,et al.  Effect of reduction of postoperative days in the intensive care unit after coronary artery bypass. , 1984, The Journal of thoracic and cardiovascular surgery.

[32]  H. Fineberg,et al.  Preferences for Health Outcomes , 1984, Medical decision making : an international journal of the Society for Medical Decision Making.

[33]  D. Cullen,et al.  Results, charges, and benefits of intensive care for critically ill patients: Update 1983 , 1984, Critical care medicine.

[34]  F. Loop,et al.  A strategy for cost containment in coronary surgery. , 1983, JAMA.

[35]  A S Detsky,et al.  Prognosis, survival, and the expenditure of hospital resources for patients in an intensive-care unit. , 1981, The New England journal of medicine.

[36]  K E Warner,et al.  Cost-Benefit and Cost-Effectiveness Analysis in Health Care: Growth and Composition of the Literature , 1980, Medical care.

[37]  G. Carlon,et al.  The inverse relationship between cost and survival in the critically ill cancer patient , 1979, Critical care medicine.

[38]  D. Cullen Results and Costs of Intensive Care , 1977, Anesthesiology.

[39]  K E Warner,et al.  Introduction to cost-benefit and cost-effectiveness analysis in health care. , 1982, Mead Johnson Symposium on Perinatal and Developmental Medicine.

[40]  S. Finkler The distinction between cost and charges. , 1982, Annals of internal medicine.